Description
S-23 + YK-11 + LGD-4033 + 5a Hydroxy Laxogenin Transdermal research stack
S-23 + YK-11 + LGD-4033 + 5a Hydroxy Laxogenin Transdermal combines three androgen receptor ligands with a plant-derived steroidal sapogenin in a transdermal research base.
Product details
| Compound | S-23, YK-11, LGD-4033 and 5α-hydroxy-laxogenin |
|---|---|
| Class | Transdermal research formula |
| Strength | 60ml/32.5mg per ml/1950mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- SARM research: androgen receptor ligands.
- Laxogenin: plant brassinosteroid-like compound research.
- Transdermal research: skin permeation of small molecules.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from heat and light.
Related research products
Mass Construction 2.0 (MK-677 + 4-Andro + LGD-4033 + YK-11) · LGD-4033 + RAD-140 + S23 Stack · S4 Andarine + Ligandrol (LGD-4033) Stack · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.